SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-075132
Filing Date
2021-06-01
Accepted
2021-06-01 17:07:49
Documents
12
Period of Report
2021-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118119d1_8k.htm   iXBRL 8-K 37706
  Complete submission text file 0001104659-21-075132.txt   212848

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA immu-20210527.xsd EX-101.SCH 3187
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20210527_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20210527_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2118119d1_8k_htm.xml XML 3606
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 21986307
SIC: 2834 Pharmaceutical Preparations